HRTX: the cashflow

MyFinsight

For the quarter ending 2025-09-30.

Cash Flow Overview

No enough data to generate the overview

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Cash Flow	2025-09-30	2025-06-30
Net loss	-17,241	-
Loss on disposal of property and equipment	-	-95
Stock-based compensation expense	8,160	5,308
Depreciation and amortization	1,777	1,162
Amortization of debt discount	505	311
Amortization of debt issuance costs	108	106
Accretion of discount on short-term investments	650	520
Retirement and impairment of property and equipment	409	-
Loss on extinguishment of debt	-11,339	-
Accounts receivable	2,166	1,050
Net loss	-	254
Inventory	16,865	19,805
Prepaid expenses and other assets	4,550	-698
Accounts payable	308	328
Accrued clinical and manufacturing liabilities	-5,787	-8,083
Accrued payroll and employee related liabilities	-806	-3,083
Other accrued expenses	7,052	4,541
Net cash used in operating activities	-18,407	-19,738
Purchases of short-term investments	38,214	32,087
Maturities and sales of short-term investments	59,914	41,958
Purchases of property and equipment	317	317
Proceeds from sale of property and equipment	82	53
Net cash provided by investing activities	21,465	9,607
Proceeds from the sale of common stock	19,838	-
Cash paid for issuance costs of stock	1,531	-
Proceeds from sale of series a convertible preferred stock	7,862	-
Cash paid for extinguishment-Two Thousand Twenty Six Senior Unsecured Convertible Notes	125,000	-
Cash paid for extinguishment-Notes Payable	25,000	-
Proceeds from notes payable issuance-Two Thousand Thirty One Senior Unsecured Convertible Notes	33,250	-
Cash paid for notes payable debt issuance cost-Two Thousand Thirty One Senior Unsecured Convertible Notes	1,386	-
Proceeds from notes payable issuance-Notes Payable	108,787	-
Cash paid for notes payable debt issuance cost-Notes Payable	3,406	-
Proceeds from purchases under the employee stock purchase plan	587	587
Receipts for stock issued under the equity incentive plan	207	258
Net cash provided by financing activities	14,208	845
Net increase (decrease) in cash and cash equivalents	17,266	-9,286
Cash and cash equivalents at beginning of period	25,802	-
Cash and cash equivalents at end of period	43,068	-

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Time Plot

Show the time plot by selecting a row from the table.

HRTX: the cashflow